Intellectual Property India Publishes Patent Application for 'Vaccines Against Respiratory Diseases' Filed by Pfizer Inc.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065114 A) filed by Pfizer Inc., New York, on July 8, for 'vaccines against respiratory diseases.'

Inventor(s) include Berman, Damon Andrew Hollands; Che, Ye; Gribenko, Alexey Vyacheslavovitch; Huang, Bridget Yih Jiin; Li, Weiqiang; Li, Yan; Swanson, Kena Anne; Wang, Helen Chen; Wellnitz, Sabine Susanne; Wong, Kam Ho; Yang, Qi; and Zhu, Aiping.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to hMPV F, PIV3 F and PIV1 F protein mutants, nucleic acids or vectors encoding a hMPV F, PIV3 F and PIV1 F protein mutant, compositions comprising a hMPV F, PIV3 F and PIV1 F protein mutant or nucleic acid, and uses of the hMPV F, PIV3 F and PIV1 F protein mutants, nucleic acids or vectors, and compositions."

The patent application was internationally filed on Jan. 16, 2024, under International application No.PCT/IB2024/050404.

Disclaimer: Curated by HT Syndication.